Effects of Liraglutide on Cardio-Metabolic Risk Markers
Effects of Liraglutide on Cardio-Metabolic Risk Markers
Incretin-based therapies have shown significant effects beyond those on glucose metabolism. We aim in the present study to evaluate the effects of liraglutide on several cardio-metabolic risk markers.
In details, we will evaluate the effects of liraglutide on carotid-intima media thickness, oxidative stress, ghrelin, heat shock proteins and lipoproteins.
Inclusion Criteria:
- patients with a diagnosis of type-2 diabetes
Exclusion Criteria:
- severe hepatic or renal diseases